Loading
Latest filing published 28 Jan 2022 for Titan Pharmaceuticals INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of James R. Mcnab in Titan Pharmaceuticals Inc, where the filings describe the role as board member. We count 2 filings; the first trade dates from 13 January 2016 and the latest from 28 January 2022.
The open-market record is one-sided, with 1 purchase and not one sale. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 28 January 2022 with a transaction in Titan Pharmaceuticals Inc. The last purchase on record was published on 14 January 2016, which is 3,929 days ago. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations